הכנסה לפני ניכוי ריבית, מסים ופחת: adialpharma.com (ADIL)
While Adial Pharmaceuticals (ADIL) undergoes complex clinical trials for its personalized agent AD04, the company is successfully implementing ESG standards and biosafety. The EBITDA history on this GURU.Markets chart shows that 0.00 captures a new operating profit level. This is driven by automated biochemical tests, which accelerate drug verification through the robotization of analysis.
Adial Pharmaceuticals, Inc. (ADIL) - פילוחי מדדים ודוחות פיננסיים
The high scalability of Adial Pharmaceuticals (ADIL) enables the generation of significant cash flow against fixed production costs for its patented drugs. This metric captures the daily balance of operating profit before depreciation and interest, reflecting the real-time balance of supply and demand, which allows for an assessment of current business efficiency through an EBITDA snapshot.
